Element Biosciences vs En Carta Diagnostics
Element Biosciences vs En Carta Diagnostics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Element Biosciences is on 53/100 and En Carta Diagnostics on 52/100.
Where each one leads
Element Biosciences
- domain rating: 66/100 against 0/100
- funding raised: $175M against $5.0M
En Carta Diagnostics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Element Biosciences | En Carta Diagnostics |
|---|---|---|
| What it is | Revolutionizing genomic analysis with innovative sequencing technology. | Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity. |
| Category | Biotechnology, Genomics, Life Sciences, Healthcare Technology | Biotechnology, HealthTech, Diagnostics, Medical Devices |
| Sells toBusiness model | B2B | B2B2C |
| Offering | Hardware | Hardware |
| Founded | 2017 | 2022 |
| Headquarters | San Diego, USA | Paris, France |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Element Biosciences | En Carta Diagnostics |
|---|---|---|
| Employees | Not published | 12 |
| Total funding | $175M | $5.0M |
| Latest round | Series E | Seed |
| Valuation | $1.1B | Not published |
| LinkedIn followers | Not published | 2,091 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Element Biosciences | En Carta Diagnostics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 52/100 |
| Traction | 40/100 | 45/100 |
| Team | Not published | 70/100 |
| Search visibility | 2/100 | 20/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (34/100) | Not published |
| Domain ratingLink authority, 0-100 | 66/100 | 0/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Element Biosciences | En Carta Diagnostics |
|---|---|---|
| CDN | Cloudflare | Not detected |
| Frameworks | Bootstrap | Not detected |
| Analytics | Google Analytics 4, Google Tag Manager | Not detected |
| Support stack | HubSpot | Not detected |
What users say
| Measure | Element Biosciences | En Carta Diagnostics |
|---|---|---|
| Reddit sentimentThreads we track | 1 positive, 0 negative across 3 threads | Not published |
“The cost of sequencing human genome has fallen from $100M to under $100 in approximately 25 years. Element Biosciences reportedly hit the $100 genome milestone (Feb 2026).”r/singularity
Element Biosciences vs En Carta Diagnostics: common questions
Which is better, Element Biosciences or En Carta Diagnostics?
On our 0-100 score Element Biosciences rates higher (53/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Element Biosciences and En Carta Diagnostics compare on the numbers?
Element Biosciences leads on domain rating (66/100 against 0/100), funding raised ($175M against $5.0M).
What do real users say about Element Biosciences and En Carta Diagnostics?
Element Biosciences: 1 positive and 0 negative mentions across 3 Reddit threads we track, mostly in r/singularity.
Read the full Element Biosciences review and pricing or the En Carta Diagnostics review and pricing. You can also browse other Element Biosciences alternatives we track.